Sort
11,323 grants matching “glioblastoma”
Vulnerabilities of MMR-deficient glioblastoma
$387,027Benjamin W. Purow · University Of Virginia · R01 · FY2024 · NS
Therapeutic resistance and aggressive malignancy in glioblastomas: the contribution of GTP metabolism through regulation by IMPDH2
$386,881Atsuo Sasaki · University Of Cincinnati · R01 · FY2025 · CA
Metabolism Informs Intertumoral & Intratumoral Heterogeneity
$386,856Jeremy N Rich · University Of California, San Diego · R01 · FY2018 · NS
Endothelial plasticity in glioma vascularization and therapy resistance
$386,788Yi Fan · University Of Pennsylvania · R01 · FY2024 · NS
Defining the role of mutant IDH in glioma initiation and maintenance
$386,786Sheri L. Holmen · University Of Utah · R01 · FY2011 · NS
Role of Parkinson's disease gene PARK2 in GBM oncogenesis and genomic instability
$386,750Timothy An-Thy Chan · Sloan-Kettering Inst Can Research · R01 · FY2015 · NS
Role of Parkinson's disease gene PARK2 in GBM oncogenesis and genomic instability
$386,750Timothy An-Thy Chan · Sloan-Kettering Inst Can Research · R01 · FY2013 · NS
Fluorescence lifetime technique for intraoperative identification of IDH mutations in brain cancer
$386,565Laura Marcu · University Of California At Davis · R21 · FY2020 · CA
Detecting invading glioma cells through in vivo molecular imaging of the cell sur
$386,462Susann M Brady-Kalnay · Case Western Reserve University · R01 · FY2011 · NS
A novel strategy to overcome the P-gp/BCRP drug efflux system at the blood-brain barrier to improve brain uptake of CNS therapeutics
$386,421Bjoern Bauer · University Of Kentucky · R01 · FY2019 · NS
Neoantigen-specific Adoptive T Cell Therapy for Glioblastoma, IND-BB-13135, protocol submitted 04/25/2020
$386,381Gary W. Wood · Tvax Biomedical, Inc. · R01 · FY2022 · FD
In vivo imaging of the stem cell loaded oncolytic viruses for cancer therapy
$386,339Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2018 · CA
In vivo SELEX strategies to identify potent aptamer-drug conjugates for glioblastoma
$386,233Jann N Sarkaria · Mayo Clinic Rochester · R61 · FY2024 · NS
Controlled Release of Macromolecules
$386,153Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2011 · EB
The role of Nrf2 in mediating resistance to EGFR inhibition in glioblastoma
$386,138Amyn Habib · Ut Southwestern Medical Center · R01 · FY2020 · CA
Elucidate and Modulate Cell Signaling in NK Cells for Glioma Treatment
$386,136Jianhua Yu · Beckman Research Institute/City Of Hope · R01 · FY2018 · AI
Engineered and Encapsulated Stem Cells for Resected Brain Tumors
$386,033Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2020 · NS
Engineered and Encapsulated Stem Cells for Resected Brain Tumors
$386,033Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2019 · NS
Engineered and Encapsulated Stem Cells for Resected Brain Tumors
$386,033Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2021 · NS
Characterization of oncogenic FGFR3-TACC3 fusion gene in glioblastoma
$385,948Wei Zhang · Wake Forest University Health Sciences · R01 · FY2016 · CA
Mechanisms of exRNA Trafficking
$385,935Xandra Owens Breakefield · Massachusetts General Hospital · U19 · FY2016 · CA
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer
$385,747Kenneth P Olive · Columbia University Health Sciences · R01 · FY2014 · CA
Regulation of Macrophage- and Microglia-mediated STING Signaling in Glioblastoma
$385,723Rongze Olivia Lu · University Of California, San Francisco · R01 · FY2025 · NS
Brain tumor recurrence via signals from vascular endothelial cells
$385,704Ichiro Nakano · University Of Alabama At Birmingham · R01 · FY2020 · NS
Neural Stem Cell Carriers for Glioblastoma Immunotherapy
$385,694Irina V Balyasnikova · Northwestern University At Chicago · R21 · FY2018 · NS